Million-Dollar Cures: Why Insurance Policy Now Decides Which Children Get Gene Therapy
A new Pediatric Research commentary argues that insurance coverage and reimbursement policy, not the underlying science, now determine which children ...
A new Pediatric Research commentary argues that insurance coverage and reimbursement policy, not the underlying science, now determine which children ...
A nationwide claims analysis found that most oral blood cancer drug prescriptions were initially rejected by insurers and that high ...
The price of saving a newborn’s life can extend far beyond the hospital walls. A new analysis published in the ...
Recent research published in JAMA Network Open highlights pivotal trends affecting access to semaglutide, a groundbreaking glucagon-like peptide-1 (GLP-1) receptor ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine